Markus Hoenicka

662 total citations
42 papers, 484 citations indexed

About

Markus Hoenicka is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Markus Hoenicka has authored 42 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 15 papers in Cardiology and Cardiovascular Medicine and 9 papers in Molecular Biology. Recurrent topics in Markus Hoenicka's work include Cardiac and Coronary Surgery Techniques (11 papers), Electrospun Nanofibers in Biomedical Applications (9 papers) and Tissue Engineering and Regenerative Medicine (8 papers). Markus Hoenicka is often cited by papers focused on Cardiac and Coronary Surgery Techniques (11 papers), Electrospun Nanofibers in Biomedical Applications (9 papers) and Tissue Engineering and Regenerative Medicine (8 papers). Markus Hoenicka collaborates with scholars based in Germany, Austria and United States. Markus Hoenicka's co-authors include Andreas Liebold, H. Schröder, R. Gerzer, Dietrich E. Birnbaum, Çhristof Schmid, Johannes-Peter Stasch, Heiner Apeler, Volker R. Jacobs, Karla Lehle and Franz X. Schmid and has published in prestigious journals such as Nature Genetics, Biomaterials and The Annals of Thoracic Surgery.

In The Last Decade

Markus Hoenicka

40 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Hoenicka Germany 15 178 132 127 125 82 42 484
Henry Shih United States 13 265 1.5× 82 0.6× 270 2.1× 229 1.8× 51 0.6× 26 672
Chengfei Peng China 12 121 0.7× 63 0.5× 59 0.5× 188 1.5× 35 0.4× 29 511
S. Lehoux Canada 7 154 0.9× 128 1.0× 121 1.0× 157 1.3× 19 0.2× 10 597
Satoshi Kimura Japan 6 142 0.8× 26 0.2× 47 0.4× 249 2.0× 68 0.8× 12 491
Motohisa Tofukuji United States 14 199 1.1× 95 0.7× 163 1.3× 160 1.3× 17 0.2× 31 517
Oliver Y. Bernecker Austria 12 171 1.0× 49 0.4× 235 1.9× 229 1.8× 12 0.1× 21 543
Christina C. Gyenge Norway 11 95 0.5× 58 0.4× 27 0.2× 152 1.2× 18 0.2× 11 421
Shiping Cao China 15 109 0.6× 41 0.3× 197 1.6× 224 1.8× 20 0.2× 28 593
Georgios Bougioukas Greece 10 120 0.7× 35 0.3× 72 0.6× 109 0.9× 16 0.2× 18 336
Robin Hinmon United States 11 110 0.6× 17 0.1× 99 0.8× 99 0.8× 34 0.4× 12 426

Countries citing papers authored by Markus Hoenicka

Since Specialization
Citations

This map shows the geographic impact of Markus Hoenicka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Hoenicka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Hoenicka more than expected).

Fields of papers citing papers by Markus Hoenicka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Hoenicka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Hoenicka. The network helps show where Markus Hoenicka may publish in the future.

Co-authorship network of co-authors of Markus Hoenicka

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Hoenicka. A scholar is included among the top collaborators of Markus Hoenicka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Hoenicka. Markus Hoenicka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hoenicka, Markus, Andreas Liebold, Vadim Sakk, et al.. (2025). Functional and molecular analyses reveal impaired HSPCs in Multiple Myeloma patients post-induction. Stem Cells Translational Medicine. 14(11). 1 indexed citations
2.
3.
Hoenicka, Markus, et al.. (2022). Effect of the analgesic metamizole (dipyrone) on volume balance and vasopressor use in cardiac surgery patients. Minerva Anestesiologica. 88(12). 1073–1074. 1 indexed citations
4.
5.
Keller, Anja, Markus Hoenicka, Andreas Liebold, et al.. (2021). Aging of human hematopoietic stem cells is linked to changes in Cdc42 activity. Haematologica. 107(2). 393–402. 30 indexed citations
6.
Hofmann, Hans‐Stefan, Christian Schneider, Rudolf Hatz, et al.. (2020). Evaluation of the combination of endothelin receptor antagonists (ERA) and phosphodiesterase-5 inhibitors for the treatment of pulmonary arterial hypertension (PAH) in pathologic human pulmonary arteries in an ex-vivo organ bath model. Pulmonary Pharmacology & Therapeutics. 66. 101985–101985. 1 indexed citations
7.
Bauernschmitt, Robert, et al.. (2019). Effects of pulsatile minimal invasive extracorporeal circulation on fibrinolysis and organ protection in adult cardiac surgery—a prospective randomized trial. Journal of Thoracic Disease. 11(S10). S1453–S1463. 3 indexed citations
8.
Hoenicka, Markus, et al.. (2019). Combination Therapy of Pulmonary Arterial Hypertension with Vardenafil and Macitentan Assessed in a Human Ex Vivo Model. Cardiovascular Drugs and Therapy. 33(3). 287–295. 2 indexed citations
9.
10.
Nakamura, Junji, et al.. (2017). Pericardial Fluids or Cardiopulmonary Bypass: Is There a Major Culprit for Changes in Coagulation and Inflammation?. The Thoracic and Cardiovascular Surgeon. 65(S 01). S1–S110. 2 indexed citations
11.
Hoenicka, Markus, et al.. (2017). Selective venous vasodilator properties of the analgesic metamizole (dipyrone) in a human ex vivo model—implications for postoperative pain management. Naunyn-Schmiedeberg s Archives of Pharmacology. 390(5). 519–526. 3 indexed citations
12.
13.
Ried, Michael, Reiner Neu, Zsolt Sziklavári, et al.. (2013). Combination of Sildenafil and Bosentan for Pulmonary Hypertension in a Human Ex Vivo Model. Cardiovascular Drugs and Therapy. 28(1). 45–51. 6 indexed citations
14.
Hoenicka, Markus, et al.. (2012). Development of endothelium-denuded human umbilical veins as living scaffolds for tissue-engineered small-calibre vascular grafts. Journal of Tissue Engineering and Regenerative Medicine. 7(4). 324–336. 14 indexed citations
15.
Hoenicka, Markus, Andreas Keyser, Leopold Rupprecht, et al.. (2011). Endothelium-Dependent Vasoconstriction in Isolated Vessel Grafts: A Novel Mechanism of Vasospasm?. The Annals of Thoracic Surgery. 92(4). 1299–1306. 8 indexed citations
16.
Hoenicka, Markus & Çhristof Schmid. (2008). Cardiovascular Effects of Modulators of Soluble Guanylyl Cyclase Activity. Cardiovascular & Hematological Agents in Medicinal Chemistry. 6(4). 287–301. 15 indexed citations
17.
Schmid, Franz‐Xaver, Nalini Vudattu, Bernhard Floerchinger, et al.. (2006). Endothelial apoptosis and circulating endothelial cells after bypass grafting with and without cardiopulmonary bypass☆. European Journal of Cardio-Thoracic Surgery. 29(4). 496–500. 19 indexed citations
18.
Jacobs, Volker R., Markus Niemeyer, Nina Gottschalk, et al.. (2005). Das STEMMAT-Projekt als Teil der Gesundheitsinitiative BayernAktiv: Adulte Stammzellen aus Nabelschnur und -blut als Alternative zur embryonalen Stammzellforschung [The STEMMAT project as part of the health initiative BayernAktiv: adult stem cells from umbilical cord and cord blood as alternative to embryonic stem cell research]. University of Regensburg Publication Server (University of Regensburg). 1 indexed citations
19.
Hoenicka, Markus, et al.. (1999). Purified soluble guanylyl cyclase expressed in a baculovirus/Sf9 system: stimulation by YC-1, nitric oxide, and carbon monoxide. Journal of Molecular Medicine. 77(1). 14–23. 100 indexed citations
20.
Becker, Eva Maria, Frank Wunder, Raimund Kast, et al.. (1999). Generation and Characterization of a Stable Soluble Guanylate Cyclase-Overexpressing CHO Cell Line. Nitric Oxide. 3(1). 55–66. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Henry Shih Breakdown of academic impact, for papers by Chengfei Peng Breakdown of academic impact, for papers by S. Lehoux Breakdown of academic impact, for papers by Satoshi Kimura Breakdown of academic impact, for papers by Motohisa Tofukuji Breakdown of academic impact, for papers by Oliver Y. Bernecker Breakdown of academic impact, for papers by Christina C. Gyenge Breakdown of academic impact, for papers by Shiping Cao Breakdown of academic impact, for papers by Georgios Bougioukas Breakdown of academic impact, for papers by Robin Hinmon
Rankless by CCL
2026